Skip to main content

What’s red and white and fights the blues?

Although the holidays are a festive time of year, for some it can be depressing. Those with drinking problems have a particularly difficult time, and I cannot in good conscience recommend alcohol as a therapy for the seasonal blues. There is some intriguing evidence however that substances in wine can help fight depression.

Two studies from the same lab at the University of Santiago in Spain looked at the activity of the wine-derived compound resveratrol, and a cousin molecule called “trans-epsilon viniferin” (which is 2 resveratrol molecules linked together) on release of the neurotransmitter serotonin. This is the same molecule that many prescription antidepressants target, and with both wine substances the levels of serotonin were elevated in the same way. Another target of antidepressants called MAO inhibitors, were similarly found to have a parallel effect from the wine derivatives. A limiting factor is that these studies were in brain tissue from rats, so it is a big leap to conclude that it will have the same effect in humans. However, we do know that resveratrol gets into the brain and has other positive effects so it certainly merits further research.

Although resveratrol levels are generally higher in red wines, white wines may have a beneficial effect as well. A study done a few years ago at a French laboratory evaluated the effects of champagne consumption in a set of human subjects. Interestingly, they observed that people tend to either have high or low baseline serotonin levels. In those with low levels (who may be at higher risk for depression) the serotonin levels were increased by more than 50% after moderate consumption of the bubbly. They also observed increases in another neurotransmitter molecule called dopamine, which may also have salutary effects.

In any case, the evidence suggests that if you don’t have a problem with alcohol, you should consider getting in the mood for some wine this season. Here’s wishing everyone a happy and healthy holiday.

Comments

Popular posts from this blog

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...

Should wine labels make health claims?

Winemakers have been in a debate for some years now with the U.S. Department of Treasury's Alcohol, Tax and Trade Bureau (formerly the ATF, for Alcohol, Tobacco, and Firearms--yeah, that made a lot of sense) about ingredient listing for wines, particularly since the healthful properties of wine polyphenols such as resveratrol have been widely publicised. A couple of years back, an Oregon pinot noir producer gained approval for a fairly benign claim: "Pinot noir develops a natural defense against botrytis (mold) in our moist, cool climate - the antioxidant resveratrol." Since resveratrol is indeed produced in the skins of grapes subjected to certain environmental stresses such as mold, and Oregon's climate is certifiably moist, it seems a fairly harmless claim. However, the feds simultaneously disallowed placing the same wording on another vintage from the same producer, citing concern about making therapeutic claims on labels or creating "misleading" associa...